EP 1919953 A1 20080514 - ANTIBODIES DIRECTED AGAINST A LDL RECEPTOR
Title (en)
ANTIBODIES DIRECTED AGAINST A LDL RECEPTOR
Title (de)
GEGEN EINEN LDL-REZEPTOR GERICHTETE ANTIKÖRPER
Title (fr)
ANTICORPS DIRIGES CONTRE LE RECEPTEUR DU LDL
Publication
Application
Priority
- FR 2006001806 W 20060725
- FR 0508282 A 20050803
Abstract (en)
[origin: WO2007014991A1] The invention relates to a monoclonal antibody directed against a human LDL (Low Density Lipoprotein) receptor bound to a corresponding peptide of 195-222 (SEQ ID NO: 1) amino acids of the LDL receptor peptide sequence, to the use thereof in the form of a drug and in immune-histochemical analysis of cancerous, healthy or cirrhosis-free or cirrhosis tissues in western blot, ELISA or in an in vivo quantification tests.
IPC 8 full level
C07K 16/28 (2006.01); A61P 35/00 (2006.01); C12N 5/20 (2006.01); C12N 15/13 (2006.01); C12N 15/63 (2006.01); G01N 33/577 (2006.01)
CPC (source: EP US)
A61P 35/00 (2017.12 - EP); C07K 16/28 (2013.01 - EP US); G01N 33/92 (2013.01 - EP US); A61K 2039/505 (2013.01 - EP US); C07K 2317/565 (2013.01 - EP US)
Citation (search report)
See references of WO 2007014991A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
FR 2889533 A1 20070209; FR 2889533 B1 20071012; AU 2006274751 A1 20070208; AU 2006274751 A8 20080410; CA 2618044 A1 20070208; EP 1919953 A1 20080514; JP 2009502188 A 20090129; US 2009175789 A1 20090709; WO 2007014991 A1 20070208
DOCDB simple family (application)
FR 0508282 A 20050803; AU 2006274751 A 20060725; CA 2618044 A 20060725; EP 06794206 A 20060725; FR 2006001806 W 20060725; JP 2008524538 A 20060725; US 98982106 A 20060725